In the Zone: Gyrolab vs ELISA

Plate-based enzyme-linked immunosorbent assays (ELISAs) are widely used due to their advantages of simplicity, high specificity and sensitivity, and technical simplicity, but are accompanied with inherent drawbacks in large sample volumes and manually intensive and time-consuming pipetting and incubation steps, and having limited assay dynamic ranges. Gyrolab technology simplifies immunoassay workflows with the use of proprietary compact disk (CD) based microfluidic labware, a flow-through 15 nL affinity column, and highly reproducible nanoliter microfluidics. When integrated with Gyrolab platforms, these microfluidic immunoassays are fully automated.

INFOGRAPHIC

INZ CAR-T

Gyrolab vs ELISA – what are the pros and cons? – This infographic focuses on the key comparisons between Gyrolab vs ELISA. Each platform is reviewed detailing differences in sample volume, manual pipetting steps, automation, assay length, assay development time, datapoints per day, assay dynamic range and data output.

 

 

PODCAST

Immunoassay applications: a podcast with John Chappellpodcast – In this podcast John Chappell (Director of Application Support and Field Service at Gyros Protein Technologies, UK) discusses how Gyrolab technology simplifies immunoassay workflows and the differences between Gyrolab assays versus ELISA.

 

 

WEBINAR

Bioanalysis Zone hexagon

Meeting evolving industry demands with smaller, faster and walkaway ligand-binding assays – In this webinar, we discuss the current state and outlook of the fast-growing biopharmaceutical industry with a special focus on the need for automation and speed in analytics, including customer case studies demonstrating performance and workflow improvements over traditional plate-based immunoassays such as ELISA in preclinical, clinical and bioprocess applications.

 

In association with